Gene: RSPRY1
Official Full Name: ring finger and SPRY domain containing 1provided by HGNC
Gene Summary: This gene encodes a glycoprotein that contains a RING-type zinc finger domain and an SPRY domain of unknown function. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Feb 2015]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO23876 | RSPRY1 Knockout cell line (HeLa) | Human | RSPRY1 | 1:3~1:6 | Negative | Online Inquiry |
KO23877 | RSPRY1 Knockout cell line (HCT 116) | Human | RSPRY1 | 1:2~1:4 | Negative | Online Inquiry |
KO23878 | RSPRY1 Knockout cell line (HEK293) | Human | RSPRY1 | 1:3~1:6 | Negative | Online Inquiry |
KO23879 | RSPRY1 Knockout cell line (A549) | Human | RSPRY1 | 1:3~1:4 | Negative | Online Inquiry |
RSPRY1 Gene Knockout Cell Lines are specialized cellular models derived from various human and animal cell types where the RSPRY1 gene has been genetically inactivated using CRISPR-Cas9 technology. These cell lines serve as powerful tools for researchers aiming to investigate the biological functions and molecular pathways influenced by RSPRY1. The knockout mechanism involves precise DNA editing that disrupts the gene’s coding sequence, leading to a lack of expression of the associated protein, thereby allowing for the elucidation of its role in cellular processes such as differentiation, proliferation, and stress response.
The scientific importance of RSPRY1 Gene Knockout Cell Lines lies in their potential applications across a range of fields, including cancer research, immunology, and genetic disorder studies. By enabling the observation of phenotypic changes in the absence of RSPRY1, these cell lines facilitate the identification of novel therapeutics and biomarkers. Furthermore, they can be utilized to understand disease mechanisms at a molecular level, contributing to the development of targeted treatments.
One of the key advantages of RSPRY1 Gene Knockout Cell Lines is their ability to provide a controlled environment for experimental manipulation, allowing researchers to reliably replicate conditions that mimic pathological states. This is complemented by ease of use, as the knockout lines are ready for application without the need for further genetic modifications. Compared to alternative models such as transient knockdowns or less stable genetic edits, these cell lines offer enhanced stability and reproducibility, making them invaluable for longitudinal studies.
Investing in RSPRY1 Gene Knockout Cell Lines provides researchers and clinicians with the essential tools to dissect the intricate roles of specific genes within the broader context of disease. Their versatile applications and robust nature enhance research productivity and facilitate deeper insights into genetic functions. Our company, with its commitment to advancing scientific inquiry through high-quality cellular models, is dedicated to supporting your research needs with expertly developed and validated products like RSPRY1 Gene Knockout Cell Lines.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.